Factors Secreted by Human Neuroblastoma Mediate Doxorubicin Resistance by Activating STAT3 and Inhibiting Apoptosis

Molecular Medicine

Volumn 7, Issue 6, 2001, Pages 393-400

  Rebbaa, Abdelhadi ^a,b   Chou, Pauline M ^a,b   Mirkin, Bernard L ^a,b  

^a Children's Mem Inst for Educ/Res   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2L1 PROTEIN, HUMAN; DNA BINDING PROTEIN; DOXORUBICIN; PROTEIN BCL 2; PROTEIN BCL X; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TYRPHOSTIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; NEUROBLASTOMA; PHOSPHORYLATION; SECRETION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CULTURE MEDIA, CONDITIONED; DNA-BINDING PROTEINS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; NEUROBLASTOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 0035376404     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402185     Document Type: Article

References (30)

1. Darnell JE Jr. (1997) Stats and gene regulation. Science 277: 1630-1635.
2. Akira S. (1999) Functional roles of Stat family proteins: lessons from knockout mice. Stem Cells 17: 138-146.
3. Takeda K, Noguchi K, Shi W, et al. (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94: 3801-3804.
4. Catlett-Falcone R, Landowski TH, Oshiro MM, et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115.
5. Grandis JR, Drenning SD, Zeng Q, et al. (2000) Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. U.S.A. 97: 4227-4232.
6. Ni Z, Lou W, Leman ES, Gao AC. (2000) Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res. 60: 1225-1228.
7. Schwarze MM, Hawley RG. (1995) Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated upregulation of bcl-xL. Cancer Res. 55: 2262-2265.
8. Peters R, Levraz S, Perey L. (1998) Apoptotic regulation in primitive hematopoietic precursors. Blood 92: 2041-2052.
9. Fujio Y, Kunisada K, Hirota H, Yamaguchi-Takihara K, Kishimoto T. (1997) Signals through gp 130 upregulate bcl-x gene expression via STAT1 binding cis-element in cardiac myocytes. J. Clin Invest. 99: 2898-2905.
10. Tolosano E, Cutufia MA, Hirsch E, et al. (1996) Ciliary neurotrophic factor constitutively expressed in the nervous system of transgenic mice protects embryonic dorsal root ganglion neurons from apoptosis. Eur. J. Neurosci 8: 521-529.
11. Zushi S, Shinomura Y, Kiyohara T, et al. (1998) Stat3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int. J. Cancer 78: 326-330.
12. Nielsen M, Kaestel CG, Eriksen KW, et al. (1999) Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13: 735-738.
13. Niu G, Heller R, Catlelt-Falcone R, et al. (1999) Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59: 5059-5063.
14. Schmitt E, Sane AT, Steyaert A, Cimoli G, Bertrand R. (1997) The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation. Biochem Cell Biol. 75: 301-314.
15. Schmitt CA, Lowe SW. (1999) Apoptosis and therapy. J. Pathol. 187: 127-137.
16. Zunino E Perego P, Pilotti S, Pratesi G, Supino R, Arcamone F. (1997) Role of apoptotic response in cellular resistance to cytotoxic agents. Pharmacol. Ther. 76: 177-185.
17. Liu R, Page C, Beidler DR, Wicha MS, Nunez G. (1999) Over-expression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model. Am. J. Pathol. 155: 1861-1867.
18. Dalton WS, Jove R. (1999) Drug resistance in multiple myeloma: approaches to circumvention. Semin. Oncol. 26: 23-27.
19. Rebbaa A, Chou PM, Vucic I, Mirkin BL, Tomita T, Bremer EG. (1999) Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vin-blastine. Clin. Cancer Res. 5: 3661-3668.
20. Uckun FM, Waddick KG, Mahajan S, et al. (1996) BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273: 1096-1100.
21. Schreiber E, Matthias P, Muller MM, Schaffner W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
22. Friesen C, Fulda S, Debatin KM. (1999) Cytotoxic drugs and the CD95 pathway. Leukemia 13: 1854-1858.
23. Muller I, Niethammer D, Bruchelt G. (1998) Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int. J. Mol. Med. 1: 491-494.
24. Porter AG, Janicke RU. (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6: 99-104.
25. Bhat GJ, Thekkumkara TJ, Thomas WG, Conrad KM, Baker KM. (1995) Activation of the Stat pathway by angiotensin II in T3CHO/AT1A cells. Cross-talk between angiotensin II and interleukin-6 nuclear signaling. J. Biol. Chem. 270: 19059-19065.
26. Zhong Z, Wen Z, Darnell JE Jr. (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and inlerleukin-6. Science 264: 95-98.
27. Catlett-Falcone R, Dalton WS, Jove R. (1999) STAT proteins as novel targets for cancer therapy. Signal transducer an activation of transcription. Curr. Opin. Oncol. 11: 490-496.
28. Biedler JL. (1994) Drug resistance: genotype versus phenotype-thirty-second G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54: 666-678.
29. Kojima H, Endo K, Moriyama H, et al. (1998) Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J. Biol. Chem. 273: 16647-16650.
30. Kunisada K, Negoro S, Tone E, et al. (2000) Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl. Acad. Sci. U.S.A. 97: 315-319.